JCM | Free Full-Text | Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach—Where Do We Stand?
The Evolving Future of PCSK9 Inhibitors | Journal of the American College of Cardiology
PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review | Journal of the American Heart Association
A Comprehensive Review of PCSK9 Inhibitors - Caroline Coppinger, Mohammad Reza Movahed, Veronica Azemawah, Lee Peyton, James Gregory, Mehrnoosh Hashemzadeh, 2022
Nutrients | Free Full-Text | Naturally Occurring PCSK9 Inhibitors
The effects of proprotein convertase subtilisin/kexin type 9 inhibitors on lipid metabolism and cardiovascular function - ScienceDirect
Lipid lowering with PCSK9 inhibitors | Nature Reviews Cardiology
Frontiers | PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects
PCSK9 Inhibitors: Ushering in a new era of Cholesterol Busters. A Comprehensive Review. - Kindle edition by Saboowala, Dr. Hakim, Saboowala, Dr. Hakim. Professional & Technical Kindle eBooks @ Amazon.com.
PCSK9 Inhibitor: Safe Alternative to Fill the Treatment Gap in Statin-Limited Conditions?
A New Era in Lipid Lowering Therapy: An update on PCSK9 Inhibition - BroadcastMed
Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment | Journal of Medicinal Chemistry
Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism | Arteriosclerosis, Thrombosis, and Vascular Biology
PCSK9 inhibition as an emerging lipid lowering therapy: Unanswered questions - ScienceDirect
Frontiers | PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects
The Evolving Future of PCSK9 Inhibitors - ScienceDirect
Lipid-Lowering Therapy and Hemorrhagic Stroke Risk | Stroke
PCSK9 Inhibitors - Family Heart Foundation
Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives | Acta Pharmacologica Sinica
PCSK9 Inhibitors: Ushering in a new era of Cholesterol Busters. A Comprehensive Review. - Kindle edition by Saboowala, Dr. Hakim, Saboowala, Dr. Hakim. Professional & Technical Kindle eBooks @ Amazon.com.
Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment | Journal of Medicinal Chemistry
PCSK9-targeted therapies: present and future approaches | Nature Reviews Cardiology
PCSK9 Inhibition: The Big Step Forward in Lipid Control | ECR Journal
Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor | Arteriosclerosis, Thrombosis, and Vascular Biology
